<- Go Home
Enovis Corporation
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company’s Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.
Market Cap
$2.1B
Volume
713.9K
Cash and Equivalents
$38.5M
EBITDA
$359.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.3B
Profit Margin
60.08%
52 Week High
$53.84
52 Week Low
$29.32
Dividend
N/A
Price / Book Value
0.79
Price / Earnings
-2.49
Price / Tangible Book Value
-4.50
Enterprise Value
$3.5B
Enterprise Value / EBITDA
9.08
Operating Income
$76.3M
Return on Equity
27.35%
Return on Assets
0.92
Cash and Short Term Investments
$38.5M
Debt
$1.5B
Equity
$2.6B
Revenue
$2.2B
Unlevered FCF
$8.2M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium